2008
This comprehensive review showed GHK-Cu switches on a wide range of tissue repair processes: attracting repair cells, boosting collagen and elastin, increasing blood-vessel growth factors (VEGF), and stimulating hair follicle enlargement. In studies on aged skin, it tightened loose skin and improved elasticity.
Pickart L
2018
Gene analysis showed GHK-Cu influences over 4,000 human genes, about 6% of the entire genome. It turns up genes for collagen, elastin and tissue repair while turning down inflammation and promoting DNA repair. It is one of the most broadly acting regenerative peptides known.
Pickart L, Margolina A
2014
GHK was found to reset gene activity in diseased cells (including cancer and COPD cells; COPD is chronic obstructive pulmonary disease, a long-term lung disease) back toward healthier states. It increased cellular 'stemness' (stem-cell-like qualities) and switched on several repair pathways at once, suggesting it works as a broad biological reset signal.
Pickart L, Vasquez-Soltero JM, Margolina A
2003
Topical GHK-Cu (applied to the skin) dramatically sped up wound healing: wounds shrank by 64.5% in the treatment group versus only 28.2% in controls by day 13. It also significantly lowered the inflammatory marker TNF-alpha and the destructive enzymes MMP-2/MMP-9 (enzymes that break down tissue).
Canapp SO, Farese JP, Schultz GS, Gowda S, et al.
2012
GHK increased the number of stem cells in skin tissue and boosted their ability to multiply. It worked by increasing integrin expression—the 'anchor proteins' that keep stem cells in their regenerative niche. This explains part of how GHK-Cu rejuvenates aging skin.
Choi HR, Kang YA, Ryoo SJ, Shin JW, et al.
1999
GHK-Cu was shown to intelligently regulate MMPs (enzymes that break down and remodel tissue during wound healing), raising them when needed to restructure tissue and lowering them to prevent excess breakdown. This 'smart regulation' helps explain why GHK-Cu improves scar quality.
Simeon A, Monier F, Emonard H, Gillery P, et al.
2006
A randomized human trial of topical GHK-Cu (applied to the skin), and the only controlled human trial of it listed in PubMed (a database of medical studies). Thirteen patients who had circumoral CO2 laser resurfacing (laser treatment of the skin around the mouth) were randomly assigned to an aftercare routine with or without GHK-Cu. Blinded evaluators and computer analysis found no significant difference between the groups in how fast redness cleared, and no significant improvement in wrinkles or overall skin quality. Everyone improved; the GHK-Cu group did not improve more. The one measure that did separate was the patients' own rating of overall skin quality (P = 0.04).
Miller TR, Wagner JD, Baack BR, Eisbach KJ
2015
This review documents that GHK is present in human plasma (the liquid part of blood), saliva and urine, and that plasma levels fall from about 200 ng/mL at age 20 to about 80 ng/mL by age 60. It reports GHK's copper binding constant (a measure of how tightly it holds copper) as log10 = 16.44, with the copper(II) ion held by the histidine imidazole nitrogen, the alpha-amino nitrogen of glycine, and a deprotonated amide nitrogen (nitrogen atoms in the peptide that grip the metal). It also summarizes animal studies in which GHK injected at a site far from the wound, or injected intraperitoneally (into the belly cavity), produced wound healing throughout the body.
Pickart L, Vasquez-Soltero JM, Margolina A
2023
In mice with smoke-induced muscle damage, GHK-Cu given by intraperitoneal injection (into the belly cavity) at 0.2 or 2 mg/kg weekly for 7 weeks reduced muscle loss and improved grip strength, showing that injected GHK-Cu reaches and acts on tissue away from the injection site. In people with COPD (chronic obstructive pulmonary disease, a long-term lung disease), plasma GHK was lower than in age-matched healthy subjects (70.3 vs 133.0 ng/mL).
Deng M, Zhang Q, Yan L, Bian Y, et al.